A new mRNA structure prediction based approach to identifying improved signal peptides for bone morphogenetic protein 2

Piers Wilkinson,Brian Jackson,Hazel Fermor,Robert Davies
DOI: https://doi.org/10.1186/s12896-024-00858-1
2024-05-24
BMC Biotechnology
Abstract:Signal peptide (SP) engineering has proven able to improve production of many proteins yet is a laborious process that still relies on trial and error. mRNA structure around the translational start site is important in translation initiation and has rarely been considered in this context, with recent improvements in in silico mRNA structure potentially rendering it a useful predictive tool for SP selection. Here we attempt to create a method to systematically screen candidate signal peptide sequences in silico based on both their nucleotide and amino acid sequences. Several recently released computational tools were used to predict signal peptide activity (SignalP), localization target (DeepLoc) and predicted mRNA structure (MXFold2). The method was tested with Bone Morphogenetic Protein 2 (BMP2), an osteogenic growth factor used clinically for bone regeneration. It was hoped more effective BMP2 SPs could improve BMP2-based gene therapies and reduce the cost of recombinant BMP2 production.
biotechnology & applied microbiology
What problem does this paper attempt to address?